Cellular Biomedicine Group is a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases utilizing proprietary cell therapy technologies. It is the result of the acquisition, transfer, commercialization, and advancement of thirty years of research and human treatment experience in cellular medicine. Its cellular research and development is the result of collaboration among scientists and doctors from the US, England, and China.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Cellular Biomedicine Group Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Cellular Biomedicine Group Inc market cap is $384.15M.
What is the 52-week high for Cellular Biomedicine Group Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Cellular Biomedicine Group Inc 52 week high is $19.76 as of September 10, 2025.
What is the 52-week low for Cellular Biomedicine Group Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Cellular Biomedicine Group Inc 52 week low is $11.48 as of September 10, 2025.
What is Cellular Biomedicine Group Inc stock price today?
Cellular Biomedicine Group Inc stock price today is $19.75.
What was Cellular Biomedicine Group Inc stock price yesterday?
Cellular Biomedicine Group Inc stock price yesterday was $19.75.
What is the PE ratio of Cellular Biomedicine Group Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Cellular Biomedicine Group Inc’s P/E ratio is -6.98.
What is the Price-to-Book ratio of Cellular Biomedicine Group Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Cellular Biomedicine Group Inc P/B ratio is 22.1746.
What is the 50-day moving average of Cellular Biomedicine Group Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Cellular Biomedicine Group Inc 50-day moving average is $18.65.